Illinois Biotechnology Innovation Organization (iBIO)

Congratulations to Xentria, Inc. on their exclusive worldwide licensing agreement with NYU to advance a promising cardiovascular therapy! 🎉 Under Tom Shea's leadership, Xentria continues to showcase Illinois' biotech excellence through strategic partnerships that could transform patient care. This collaboration between Xentria and NYU Langone Health exemplifies the innovative spirit driving our life sciences ecosystem forward. Read more here:https://lnkd.in/gE--9F8m Proud to see Illinois biotech companies leading the way in therapeutic development! 💫 #IllinoisBiotech #LifeSciences #Innovation

🎉 2024: A Year of Growth in Illinois Life Sciences In today's iBIO NewsBrief, President & CEO John Conrad and Board Chair Kenneth Johnson reflect on our community's remarkable achievements, with 7.5% job growth since 2019 (20x Illinois' private sector rate), over 93,400 life sciences professionals, and expansion to 300+ member companies. "From startups to global pharmaceutical and medtech companies, iBIO is expanding to support its members and ensure they have the right business climate to grow and innovate," shares Ken Johnson, SVP of Global Development and Medical Affairs at Xeris Pharmaceuticals and iBIO Board Chair. Read the full conversation in today's NewsBrief to learn about our exciting plans for 2025! https://lnkd.in/gpKuw27N #LifeSciences #Illinois #Innovation #Biotechnology

Thank you Kyle LaHucik for this insightful piece highlighting Chicago's growing life sciences ecosystem. Our CEO John Conrad shared our vision of building a unique biotech hub that leverages Chicago's strengths and collaborative spirit. We're proud to see so many community leaders contribute their perspectives to this story: John Flavin, CEO of Portal Innovations, LLC , offering valuable insights on our ecosystem's steady, sustainable growth Michelle Burbea Hoffmann , Executive Director of Chicago Biomedical Consortium, bringing her experienced perspective from Boston to highlight our city's tenacious spirit Jim Sullivan, iBIO Board Member and Vanqua Bio CEO, demonstrating his commitment to building and scaling in Chicago This collection of voices shows the strength and dedication of our life sciences community. We're excited to continue working together to build Chicago's unique biotech future.

In today's iBIO NewsBrief, we spotlight two critical developments in the fight against antimicrobial resistance (AMR): Meitheal Pharmaceuticals, Inc. bold move to secure U.S. rights to XENLETA®, and the powerful story of Ella Balasa, whose battle with cystic fibrosis puts a human face on this growing crisis. "Every breath is a reminder of what's at stake," says Balasa, who shared her harrowing experience with drug-resistant infections at the UN General Assembly. "We are running out of time – and options." The statistics are startling: by 2050, AMR could contribute to 170 million deaths globally. But behind every number is someone like Ella, fighting for their next breath. That's why innovations like XENLETA® and companies willing to champion new antibiotics are crucial for our future. Read today's NewsBrief to learn how this development, combined with proposed policies like the PASTEUR Act, could help transform the future of antibiotic development and save countless lives. Read more in today's NewsBrief: https://lnkd.in/gcTFR_Tz #AMR #Healthcare #Biotechnology #PublicHealth #Innovation #PatientVoices

Thank you Opera Bioscience and CEO Gerry Sapienza for stepping up as one of the first donors to our new LabShare program! Your generous donation of lab equipment will help Illinois students experience hands-on science and see themselves as future scientists. LabShare connects surplus lab equipment from life sciences companies with Illinois schools that need it most - creating opportunities in science education and reducing waste at the same time. It's a win-win for our biotech community and our students! Want to join Opera Bioscience in making a difference? Whether you have equipment to donate or are a school looking for resources, visit our website to learn more about LabShare: https://lnkd.in/g3XaeVzm Together, we can inspire the next generation of Illinois scientists! 🔬🧬 #ILBiotech #STEM #GivingBack #ScienceEducation #Sustainability

Excited to share Illinois' remarkable momentum in the new TECONOMY/BIO report! 🚀 • 93,402 high-paying jobs (growing 20x faster than private sector) • Ranked 4th nationally in venture capital ($11.1B) • Top 10 in R&D, NIH funding, and patents Beyond the numbers lies what matters most: every breakthrough brings us closer to helping patients live longer, healthier lives. Congratulations to our entire life sciences community on these achievements! #LifeSciences #Illinois #Innovation #Biotech

🎉 We are excited to announce the release of the 11th biennial Biotechnology Innovation Organization and Council of State Bioscience Associations (CSBA) report: "The U.S. Bioscience Economy: Driving Economic Growth and Opportunity in States and Regions" The results for Illinois are remarkable! 🚀 📈 Key Highlights: • Jobs growing 7.5% since 2019 (20x faster than private sector) • 93,402 workers across 5,000 establishments • Average salaries of $153,000 (2x state average) • Ranked 4th nationally in venture capital ($11.1B invested) • Top 10 in academic R&D ($2.0B) • Top 10 in NIH funding ($1.2B, up 20% since 2019) • Top 10 in patents filed "What's particularly exciting is how our ecosystem continues to expand and mature. Our world-class research universities are powerful drivers of discovery, and our top-tier national rankings in R&D, NIH funding, patents, and venture capital demonstrate the tremendous confidence in Illinois' life sciences ecosystem." - John Conrad, President & CEO Beyond the numbers lies our true mission: every breakthrough, every startup, every job we create brings us closer to treatments and cures that help people live longer, healthier lives. The future of life sciences in Illinois is bright! 💫 Read our announcement and full report here: https://lnkd.in/gHrBSFcR #LifeSciences #Illinois #Innovation #Biotech #Healthcare #EconomicDevelopment #Research What aspect of Illinois' life sciences growth excites you the most? Share your thoughts below! 👇

🎉 Thrilled to congratulate iBIO member Cour Pharmaceuticals Development Co., Inc. on their transformative collaboration with Genentech! This potential $900M+ partnership will advance COUR's innovative tolerogenic nanoparticle platform for autoimmune conditions. Proud to see Illinois life sciences leading breakthrough therapeutic development. Well done to CEO Dannielle Appelhans and the entire COUR team! Read more: https://lnkd.in/gREB8Yze #IllinoisBiotech #LifeSciences #BiotechInnovation

🎉 Congratulations to our member Xeris Pharmaceuticals, Inc. for being named to Deloitte's 2024 Technology Fast 500! What an incredible achievement to be recognized among North America's fastest-growing tech and life sciences companies. Your innovative work in developing life-changing treatments and recent partnership with Beta Bionics exemplify the groundbreaking advances happening right here in Chicago's biotech community. We're proud to have companies like Xeris driving innovation and growth in Illinois' life sciences ecosystem. Here's to your continued success! Read the news in today's NewsBrief: https://lnkd.in/g63ZfuWU #LifeSciences #BiotechInnovation #Chicago #DeloitteFast500 #IllinoisInnovation

With Thanksgiving around the corner and holiday shopping in full swing, we're excited to share a meaningful way to make your purchases count. Introducing iBIO's STEMINIST collection - stylish sweatshirts and tees that directly support our STEM camps for girls in underserved communities. In 2024, we've helped 128 girls discover their inner scientist, with 46% now seeing themselves in STEM careers. By wearing STEMINIST gear, you're not just making a fashion statement - you're investing in future innovators. This Giving Tuesday, declare yourself a STEMINIST! Shop now: https://bit.ly/3V1uK66 #GivingTuesday #STEMINIST #GirlsInSTEM #WomenInSTEM #STEM